Iceland· IS-EU/1/00/156/002-004

Trizivir

A zidovudine, lamivudine and abacavir product containing zidovudinum inn,abacavirum inn súlfat,lamivudinum inn, registered in Iceland by ViiV Healthcare BV. The same ATC class is registered in 10 of our 19 countries.

ATC J05AR04

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedTrizivirATCJ05AR04REGISTER NO.IS-EU/1/00/156/002-004PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Zidovudine, lamivudine and abacavir is registered in 10 of 19 countries.

Countries holding a registration under ATC J05AR04 (zidovudine, lamivudine and abacavir), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Zidovudine, lamivudine and abacavir · ATC J05AR04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Zidovudinum INN,Abacavirum INN súlfat,Lamivudinum INN
Manufacturer
ViiV Healthcare BV
Country
Iceland (IS)
ATC code
J05AR04
ATC class
Zidovudine, lamivudine and abacavir
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for zidovudine, lamivudine and abacavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zidovudine, lamivudine and abacavir · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Zidovudine, lamivudine and abacavir in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zidovudine, lamivudine and abacavir products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • France · Abacavir/Lamivudine/Zidovudine Viatris
  • Italy · Abacavir/Lamivudina/Zidovudina Mylan
  • Liechtenstein · Trizivir
  • Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
  • Norway · Trizivir

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa7635d1-8a58-4561-8c9d-47a95329f0ed
GET /v1/drugs/fa7635d1-8a58-4561-8c9d-47a95329f0ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "J05AR04",
  "marketed": false,
  "strength": null,
  "ma_number": "EU/1/00/156/002-004",
  "substance": "Zidovudinum INN,Abacavirum INN súlfat,Lamivudinum INN",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "36945"
}

See everything about zidovudine, lamivudine and abacavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.